The present invention relates to a recombinant baculovirus comprising: (a) a nucleotide sequence encoding a foreign virus envelope protein (b) a first promoter operatively linked to the envelope-encoding nucleotide sequence (c) a nucleotide sequence encoding an antigen protein and (d) a second promoter operatively linked to the antigen-encoding nucleotide sequence and a vaccine composition using the same. The recombinant baculovirus of the present invention has an excellent efficacy on both humoral and cellular immune responses against a specific antigen (e.g., HPV L1), enabling to function as a more efficient DNA vaccine.
